98%
921
2 minutes
20
[F]Gln-OSOF, [F]Arg-OSOF, and [F]FSY-OSOF were designed by introducing sulfonyl F-fluoride onto glutamine, arginine, and tyrosine, respectively. [F]FSY-OSOF can be prepared directly by sulfur F-fluoride exchange, while [F]Gln-OSOF and [F]Arg-OSOF require a two-step labeling method. Those tracers retain their typical transport characteristics for unmodified amino acids. Both PET imaging and biodistribution confirmed that [F]FSY-OSOF visualized MCF-7 and 22Rv1 subcutaneous tumors with high contrast, and its tumor-to-muscle ratio was better than that of [F]FET. However, [F]Gln-OSOF and [F]Arg-OSOF poorly image MCF-7 subcutaneous tumors, possibly due to differences in the types and amounts of transporters expressed in tumors. All three tracers can visualize the U87MG glioma. According to our biological evaluation, none of the tracers evaluated in this study exhibited obvious defluorination, and subtle structural changes led to different imaging characteristics, indicating that the application of sulfur F-fluoride exchange click chemistry in the design of radioactive sulfonyl fluoride amino acids is feasible and offers significant advantages.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10860173 | PMC |
http://dx.doi.org/10.1021/acsmedchemlett.3c00557 | DOI Listing |
ACS Med Chem Lett
February 2024
Beijing Institute of Brain Disorders, Laboratory of Brain Disorders, Ministry of Science and Technology, Collaborative Innovation Center for Brain Disorders, Capital Medical University, Beijing 100069, China.
[F]Gln-OSOF, [F]Arg-OSOF, and [F]FSY-OSOF were designed by introducing sulfonyl F-fluoride onto glutamine, arginine, and tyrosine, respectively. [F]FSY-OSOF can be prepared directly by sulfur F-fluoride exchange, while [F]Gln-OSOF and [F]Arg-OSOF require a two-step labeling method. Those tracers retain their typical transport characteristics for unmodified amino acids.
View Article and Find Full Text PDFPharmaceutics
December 2023
Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research, Bautzner Landstraße 400, D-01328 Dresden, Germany.
Early detection and treatment of cancers can significantly increase patient prognosis and enhance the quality of life of affected patients. The emerging significance of the tumor microenvironment (TME) as a new frontier for cancer diagnosis and therapy may be exploited by radiolabeled tracers for diagnostic imaging techniques such as positron emission tomography (PET). Cancer-associated fibroblasts (CAFs) within the TME are identified by biomarkers such as fibroblast activation protein alpha (FAPα), which are expressed on their surfaces.
View Article and Find Full Text PDFReact Chem Eng
September 2023
Centre for Biomedicine and Positron Emission Tomography Research Centre, Hull York Medical School and University of Hull Cottingham Road Hull HU6 7RX UK
Sulfur-[F]fluoride exchange radiochemistry is a rapid and convenient method for incorporating fluorine-18 into biologically active molecules. We report a fully automated radiolabelling procedure for the synthesis of a [F]SOF-bearing prostate specific membrane antigen (PSMA) targeted ligand ([F]5) using the GE FASTLab™ cassette-based platform in a 25.0 ± 2.
View Article and Find Full Text PDFACS Omega
October 2023
Department of Nuclear Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang Avenue, Wuhan 430030, China.
The click chemistry of sulfur(VI) fluoride exchange (SuFEx) has facilitated the widespread application of sulfur-fluoride compounds such as sulfonyl fluorides, fluorosulfates, and sulfamoyl fluorides in various fields, especially in the development of F ligands for PET (positron emission tomography) imaging. In recent years, the prominent progress of sulfur-[F]fluoride compounds has been achieved through the combination of F and sulfur-fluoride chemistry. These compounds serve as potential F tracers, F synthons, and reagents for F-fluorination, thereby complementing the range of F ligands, typically C-F structures, used in PET studies.
View Article and Find Full Text PDFFront Chem
June 2021
Institute for Nanoscale Science and Technology, College of Science and Engineering, Flinders University, Adelaide, SA, Australia.
The ability to radiolabel proteins with [F]fluoride enables the use of positron emission tomography (PET) for the early detection, staging and diagnosis of disease. The direct fluorination of native proteins through C-F bond formation is, however, a difficult task. The aqueous environments required by proteins severely hampers fluorination yields while the dry, organic solvents that promote nucleophilic fluorination can denature proteins.
View Article and Find Full Text PDF